Study Evaluating Impact of the Use of a Computer-based Tool on the Clinical Management of RA Patients

Pfizer321 enrolled

Overview

The primary purpose of this study is to evaluate a computer-based tool on the clinical management of patients with rheumatoid arthritis in Spain.

Study Type

OBSERVATIONAL

Enrollment

321

Conditions

Rheumatoid Arthritis

Interventions

Review of clinical recordsOTHER

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: Main Inclusion Criteria: * Patients, male or female, over 18 years old. * Patients diagnosed with RA according to investigator criteria * Patients with a disease evolution \>= 1 year * Patients with \> = 5 affected joints Exclusion Criteria: Exclusion Criteria: * Patients with other muscle skeletal, rheumatic and/or degenerative diseases different from RA. * Patients who are taking part or have taken part in a clinical trial or in a study with drugs within the last 12 months. Any condition that, in the investigator's judgment would interfere with the subject's ability to comply with protocol requirements or give informed consent.

Outcomes

Primary Outcomes

Global mean DAS28 at 6 and at 12 months of follow-up. Differences between global mean DAS28 at 6 and at 12 months compared to baseline

Time frame: 12 months

Secondary Outcomes

Disease activity (DAS28; number affected joints; CRP; ESR; PGA).-Number of variables used in patient's follow-up; number of treatment adjustments. -Investigator's satisfaction with the computer-based tool (specific questionnaire)

Time frame: 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.